Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

Mostrar otras versiones (2)

The novel pandemic betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected at least 120 million people since its identification as the cause of a December 2019 viral pneumonia outbreak in Wuhan, China(1,2). Despite the unprecedented pace of vaccine development, wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikegame, Satoshi, Siddiquey, Mohammed N. A., Hung, Chuan-Tien, Haas, Griffin, Brambilla, Luca, Oguntuyo, Kasopefoluwa Y., Kowdle, Shreyas, Vilardo, Ariel Esteban, Edelstein, Alexis, Perandones, Claudia, Kamil, Jeremy P., Lee, Benhur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043464/
https://www.ncbi.nlm.nih.gov/pubmed/33851150
http://dx.doi.org/10.21203/rs.3.rs-400230/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043464/
https://www.ncbi.nlm.nih.gov/pubmed/33851150
http://dx.doi.org/10.21203/rs.3.rs-400230/v1

Ejemplares similares